Curaleaf (OTCMKTS:CURLF) Hits New 1-Year Low – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLFGet Free Report) hit a new 52-week low on Wednesday . The company traded as low as $2.10 and last traded at $2.18, with a volume of 3239421 shares traded. The stock had previously closed at $3.12.

Wall Street Analyst Weigh In

Several analysts have issued reports on CURLF shares. Needham & Company LLC restated a “buy” rating and issued a $6.25 price objective on shares of Curaleaf in a research note on Thursday, August 8th. Cormark upgraded Curaleaf from a “hold” rating to a “moderate buy” rating in a research note on Monday, August 12th.

Read Our Latest Stock Analysis on CURLF

Curaleaf Trading Down 30.3 %

The company has a market cap of $1.41 billion, a price-to-earnings ratio of -6.21 and a beta of 0.86. The company has a current ratio of 1.09, a quick ratio of 0.50 and a debt-to-equity ratio of 0.83. The business’s 50 day moving average price is $3.01 and its 200-day moving average price is $3.85.

Curaleaf (OTCMKTS:CURLFGet Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.01). Curaleaf had a negative return on equity of 14.75% and a negative net margin of 18.59%. The company had revenue of $342.29 million for the quarter, compared to analyst estimates of $344.57 million. On average, equities analysts anticipate that Curaleaf Holdings, Inc. will post -0.24 EPS for the current fiscal year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Stories

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.